Benitec Biopharma (BNTC) Liabilities and Shareholders Equity (2019 - 2026)
Benitec Biopharma (BNTC) reported Liabilities and Shareholders Equity of $182.62 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 83.4% from $99.59 million a year earlier.
Powered by 
Analysis
Benitec Biopharma (BNTC) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends
Dating back to fiscal Q4 2019, Benitec Biopharma's Liabilities and Shareholders Equity record includes 25 quarters.
- Liabilities and Shareholders Equity has a five-year compound annual growth rate of 53.6% (FY2021 to FY2026).
- By fiscal year, Liabilities and Shareholders Equity came in at $99.59 million in FY2025 (+90.8%), $52.21 million in FY2024, $4.46 million in FY2023 (-25.3%) and $5.97 million in FY2022 (-72.1%).
- Five-year quarterly Liabilities and Shareholders Equity spans a low of $4.46 million in fiscal Q4 2023 and a high of $190.68 million in fiscal Q2 2026.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was fiscal Q3 2025 (growth of 601.4%); the low point was fiscal Q4 2022 (a decline of 72.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Benitec Biopharma | 465.58 Mn | 465.58 Mn | - | 182.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 182.62 Mn |
| Dec 31, 2025 | 190.68 Mn |
| Sep 30, 2025 | 96.03 Mn |
| Jun 30, 2025 | 99.59 Mn |
| Mar 31, 2025 | 105.21 Mn |
| Dec 31, 2024 | 79.07 Mn |
| Sep 30, 2024 | 68.77 Mn |
| Jun 30, 2024 | 52.21 Mn |
| Mar 31, 2024 | 15.00 Mn |
| Dec 31, 2023 | 21.35 Mn |
| Sep 30, 2023 | 27.05 Mn |
| Jun 30, 2023 | 4.46 Mn |
| Mar 31, 2023 | 8.22 Mn |
| Dec 31, 2022 | 11.91 Mn |
| Sep 30, 2022 | 18.12 Mn |
| Jun 30, 2022 | 5.97 Mn |
| Mar 31, 2022 | 10.06 Mn |
| Dec 31, 2021 | 14.01 Mn |
| Sep 30, 2021 | 17.84 Mn |
| Jun 30, 2021 | 21.38 Mn |
API Access
Benitec Biopharma Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BNTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "BNTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BNTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();